Increased glutamine:fructose-6-phosphate amidotransferase activity in skeletal muscle of patients with NIDDM

Diabetes

Volumn 45, Issue 3, 1996, Pages 302-307

  Yki Järvinen, Hannele ^a   Daniels, Marc C ^c   Virkamäki, Antti ^b   Mäkimattila, Sari ^b   DeFronzo, Ralph A ^a   McClain, Don ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; FRUCTOSE 6 PHOSPHATE; GLUTAMINE;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0030042488     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.3.302     Document Type: Article

References (51)

1. Rossetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 13:610-630, 1990
2. Yki-Jarvinen H: Glucose toxicity. Endocr Rev 13.415-431, 1992
3. Traxinger RR, Marshall S: Role of amino acids in modulating glucose-induced desensitization of the glucose transport system. J Biol Chem 264:20910-20916, 1989
4. Marshall S, Bacote V, Traxinger RR Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance J Biol Chem 266:4706-4712, 1991
5. Daniels MC, Kansal P, Smith TM, Paterson AJ, Kudlow JE, McClain DA Glucose regulation of transforming growth factor alpha expression is mediated by products of the hexosamine biosynthesis pathway. Mol Endocrinol 7:1041-1048, 1993
6. McClain DA, Paterson AJ, Roos MD, Wei X, Kudlow JE: Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci USA 80:8150-8154, 1992
7. Crook ED, Zhou J, Daniels M, Neigih JL, McClain DA: Regulation of glycogen synthase by glucose, glucosamine, and glutamine fructose-b-phosphate amidotransferase. Diabetes 44:314-320, 1995
8. Crook ED, Daniels MC, Smith TM, McClain DA. Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine fructose-6-phosphate amidotransferase in rat-1 fibroblasts. Diabetes 42: 1289-1296, 1993
9. Robinson KA, Sens DA, Buse MG: Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Diabetes 42:1333-1346, 1993
10. Marshall S, Bacote V, Traxinger RR: Complete inhibition of glucose-induced desensitization of the glucose transport system by inhibitors of mRNA synthesis. J Biol Chem 266:10155-10161, 1991
11. Yki-Järvinen H: Acute and chronic effects of hyperglycemia on glucose metabolism. Diabetologia 33:579-585, 1990
12. Zierath JR, Galuska D, Nolte LA, Thorne A, Sniedegaard Kristensen J, Wallberg-Henriksson H: Effect of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 37:270-277, 1994
13. Chen W, Barzilai N, Rossetti L In vivo testing of the "glucosamine hypothesis" for glucose induced insulin resistance (Abstract). Diabetes 43 (Suppl 1):132A, 1994
14. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322:223-228, 1990
15. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
16. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30:1000-1007, 1981
17. Yki-Järvinen H, Mott D, Young AA, Stone K, Bogardus C: Regulation of glycogen synthase and phosphorylase activities by glucose, insulin and basal enzyme activity in human skeletal muscle. J Clin Invest 80:95-100, 1987
18. Ferrannini E: The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301, 1988
19. Yki-Järvinen H: Fate of glucose in insulin resistant states. In Diabetes, Obesity and Hyperlipidemia: V The Plurimetabolic Syndrome. Crepaldi G, Tiengo A, Manzato E, Eds. Amsterdam, Elsevier, 1993, p. 75-82
20. Aftring RP, Manof PN, Buse MG: Catabolism of branch chained amino acids by diaphragm muscles in fasted and diabetic rats. Metabolism 34:702-711, 1985
21. Roth M: Fluorescence reaction for amino acids. Anal Chem 43:880-882, 1971
22. Kadish AH, Little RL, Sternberg JC: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131, 1968
23. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay J Clin Endocrinol Metab 33:732-738, 1971
24. Hebert LF, McClain DA: Overexpression of glutamine:fructose-6-phosphate in skeletal muscle of transgenic mice results in insulin resistance (Abstract). Diabetes 44 (Suppl. 1):15A, 1995
25. Elkebbi I, Roser S, Pollet KJ: Regulation of glucose transport by glucosamine in cultured myocytes (Abstract). Diabetes 43 (Suppl. 1): 127A, 1994
26. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79:1510-1515, 1987
27. Kornfeld R: Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. J Biol Chem 242:3135-3141, 1967
28. Frisa PS, Sonnebon DR: Developmentally regulated interconversions between end product-inhibitable and noninhibitable forms of a first pathway-specific enzyme activity can be mimicked by protein dephosphorylation-phosphorylation reactions. Proc Natl Acad Sci USA 79:6289-6293, 1982
29. McKnight GL, Mudri SL, Matewest SL, Traxinger RR, Marshall S, Sheppard PO, O'Hara PJ: Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amidotransferase J Biol Chem 267:25208-25212, 1992
30. Kelley DE, Mandarino LJ: Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest 86:1999-2007, 1990
31. Traxinger RR, Marshall S Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. J Biol Chem 266:10148-10154, 1991
32. Yki-Järvinen H, Young AA, Lamkin C, Foley JE: Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest 79:1713-1719, 1987
33. DeFronzo RA. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389-397, 1992
34. Yki-Järvinen H, Helve E, Sane T, Nurjhan N, Taskinen M-R: Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM. Am J Physiol 256:E732-E739, 1989
35. Buse MG, Robinson K, Marshall B, Mueckler M: The hexosamine synthesis pathway in mice overexpressing GLUT1 (Abstract). Diabetes 44 (Suppl 1) 15A, 1995
36. Mueckler M: Facilitative glucose transporters Eur J Biochem 219:713-725, 1994
37. Yki-Järvinen H, Nikkilä E, Helve E, Taskinen M-R: Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am J Med 84:185-192, 1988
38. Yki-Järvinen H, Koivisto VA: Natural course of insulin resistance in type 1 diabetes. N Engl J Med 315:224-230, 1986
39. Yki-Jarvinen H, Taskinen M-R, Kiviluoto T, Hilden H, Helve E, Koivisto VA, Nikkilä E: Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro. J Clin Endocrinol Metab 59:1183-1192, 1984
40. Banerji MA, Chaiken RL, Gordon D, Kral JG, Lebovitz HE: Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive? Diabetes 44:141-146, 1995
41. Nuutila P, Knuuti MJ, Heinonen OJ, Ruotsalainen U, Teras M, Bergman J, Solin O, Yki-Jarvinen H, Voipio-Pulkki L-M, Wegelius U, Koivisto VA: Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. J Clin Invest 93:2267-2274, 1994
42. Reinmuth OM, Scheinberg P, Bourne B: Total cerebral blood flow and metabolism. Arch Neurol 12:49-66, 1965
43. 1C]glucose uptake and metabolism in the brain of insulin-dependent diabetic subjects. Am J Physiol 258:E805-E812, 1990
44. Scheinberg P, Stead EAJ: The cerebral blood flow in male subjects as measured by the nitrous oxide technique: normal values for blood flow, oxygen utilization, glucose utilization and peripheral resistance, with observations of the effect of tilting and anxiety. J Clin Invest 28:1163-1149, 1949
45. Nuutila P, Knuuti J, Ruotsalainen U, Koivisto VA, Eronen E. Teräs M, Bergman J, Haaparanta M, Voipio-Pulkki L, Viikari J, Rönnemaa T, Wegelius U, Yki-Järvinen H: Insulin resistance is localized to skeletal muscle but not heart muscle in type 1 diabetes. Am J Physiol 264:E756-E762, 1993
46. Nuutula P, Koivisto VA, Knuuti J, Ruotsalainen U, Teräs M, Haaparanta M, Bergman J, Solin O, Voipio-Pulkki L, Wegelius U, Yki-Järvinen H: The glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89:1767-1774, 1992
47. Wisneski JEG, Sertz EW, Neese RA, Sruenke LD, Morris DL, Craig JC: Metabolic fate of extracted glucose in human myocardium. J Clin Invest 76:1819-1827, 1985
48. Yki-Järvinen H, Sahlin K, Ren JM, Koivisto VA: Localization of the rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type 1 diabetic patients. Diabetes 39:157-167, 1990
49. Thomburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR: Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85.522-529, 1990
50. Vaag A, Damsbo P, Hother-Nielsen O, Beck-Nielsen H: Hyperglycemia compensates for the defects in insulin-stimulated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35:80-88, 1992
51. Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H: Multiple defects in both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia 38:326-336, 1995